With baby KJ successfully receiving the world’s first personalized CRISPR therapy, alongside continued innovation across in vivo and base editing, and rapid ex vivo clinical progress, the genome editing field stands at a pivotal juncture.
Unite with the industry’s leading minds, as they advance delivery specificity, spearhead in vivo editing, ensure precise targeting, improve translatability, and build robust clinical strategies to unlock precise, durable and safe therapeutics.
The 2025 Expert Speaker Line-up Includes:
- Kiran Musunru, Professor, Translational Research, University of Pennsylvania
- TJ Cradick, Chief Technology Officer, HuidaGene Therapeutics
- Nageswara Kollu, Senior Director, Gene Therapy, Apellis Pharmaceuticals
- Alexandria Petrusich, Vice President, Clinical Science, Prime Medicine
- Bradley Ringeisen, Executive Director, Innovative Genomics Institute
- Chris Brown, Vice President, Discovery, Metagenomi
- Anjulika Chawla, Vice President, Medical Affairs, Clinical Lead, Bluebird Bio
Alongside 20+ data-driven presentations, this year’s program will feature a deep-dive workshop dedicated to the impact of baby KJ, led by Innovative Genomics Institute, HuidaGene Therapeutics and the University of Pennsylvania.
Ensure you are part of the most anticipated gene editing event of the year!
To know more visit: https://ter.li/rd7cax